Comparative Effects of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Coronary Collateral Development and the Arterial Response to Injury
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Background We have shown that the angiogenic peptides basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) enhance canine coronary collateral development when administered for ≥4 weeks. bFGF, a pluripotent mitogen of mesodermally derived cells, could theoretically exacerbate neointimal smooth muscle cell hyperplasia, a fundamental component of atherosclerosis. VEGF, an endothelial cell–specific mitogen and vascular permeability factor, could have deleterious effects related to vascular hyperpermeability. The present investigation had two aims: (1) to ascertain whether brief (7-day) systemic arterial treatment with bFGF or VEGF would improve myocardial collateral perfusion and (2) to determine whether these peptides induce neointimal accumulation in vivo. Methods and Results Dogs were subjected to ameroid-induced occlusion of the left circumflex coronary artery and randomized to bFGF 1.74 mg (n=9), VEGF 0.72 mg (n=9), or saline (n=10) as a daily left atrial bolus (days 10 to 16). Additional dogs were randomized to VEGF 0.72 mg (n=6) or saline (n=5); however, treatment was delayed by 1 week. Coincident with the institution of treatment, all dogs underwent balloon denudation injury of the iliofemoral artery. bFGF markedly increased maximal collateral flow but did not exacerbate neointimal accumulation. VEGF had no discernible effect on maximal collateral flow, but it exacerbated neointimal thickening after vascular injury. Conclusions Short-term treatment with bFGF enhanced collateral development without increasing neointimal accumulation at sites of vascular injury. Although VEGF did not increase collateral development as administered in this study, it significantly exacerbated neointimal accumulation. These data provide support for the clinical investigation of bFGF in selected patients with ischemic heart disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,061
Blood flow measurements with radionuclide-labeled particles
Heymann, M. A., Payne, B. D., Hoffman, J. I. E., & Rudolph, A. M. (1977) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(77)80005-4 · Cited by 2,036
Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
FERRARA, N., HOUCK, K., JAKEMAN, L., & LEUNG, D. W. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-18 · Cited by 1,655
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.
Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., & Feder, J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114322 · Cited by 1,265
Dowdy, S., Weardon, S., & Chilko, D. (2004) · Wiley Series in Probability and Statistics · doi:10.1002/0471477435 · Cited by 1,150
Takeshita, S., Zheng, L. P., Brogi, E., Kearney, M., Pu, L. Q., Bunting, S., Ferrara, N., Symes, J. F., & Isner, J. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117018 · Cited by 1,036
Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., Pan, Y. C., Olander, J. V., Connolly, D. T., & Stern, D. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1535 · Cited by 835
Cited by
A review on coronary artery disease, its risk factors, and therapeutics
Malakar, A. K., Choudhury, D., Halder, B., Paul, P., Uddin, A., & Chakraborty, S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28350 · Cited by 1,141
Vascular endothelial growth factor enhances atherosclerotic plaque progression
Celletti, F. L., Waugh, J. M., Amabile, P. G., Brendolan, A., Hilfiker, P. R., & Dake, M. D. (2001) · Nature Medicine · doi:10.1038/86490 · Cited by 708
Simons, M., Annex, B. H., Laham, R. J., Kleiman, N., Henry, T., Dauerman, H., Udelson, J. E., Gervino, E. V., Pike, M., Whitehouse, M. J., et al. (2002) · Circulation · doi:10.1161/hc0802.104407 · Cited by 645
Mikos, A. G., Herring, S. W., Ochareon, P., Elisseeff, J., Lu, H. H., Kandel, R., Schoen, F. J., Toner, M., Mooney, D., Atala, A., et al. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.3307 · Cited by 598
Atala, A., Kasper, F. K., & Mikos, A. G. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004890 · Cited by 544
Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris
Grines, C. L., Watkins, M. W., Helmer, G., Penny, W., Brinker, J., Marmur, J. D., West, A., Rade, J. J., Marrott, P., Hammond, H. K., et al. (2002) · Circulation · doi:10.1161/hc1102.105595 · Cited by 519
Fuchs, S., Baffour, R., Zhou, Y. F., Shou, M., Pierre, A., Tio, F. O., Weissman, N. J., Leon, M. B., Epstein, S. E., & Kornowski, R. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01200-1 · Cited by 478
Self-citationRole of Angiogenesis in Cardiovascular Disease: A Critical Appraisal
Khurana, R., Simons, M., Martin, J. F., & Zachary, I. C. (2005) · Circulation · doi:10.1161/circulationaha.105.535294 · Cited by 451
Inoue, M., Itoh, H., Ueda, M., Naruko, T., Kojima, A., Komatsu, R., Doi, K., Ogawa, Y., Tamura, N., Takaya, K., et al. (1998) · Circulation · doi:10.1161/01.cir.98.20.2108 · Cited by 449
Novel biomaterial strategies for controlled growth factor delivery for biomedical applications
Wang, Z., Wang, Z., Lu, W. W., Zhen, W., Yang, D., & Peng, S. (2017) · NPG Asia Materials · doi:10.1038/am.2017.171 · Cited by 446
Polymeric Growth Factor Delivery Strategies for Tissue Engineering
Chen, R. R., & Mooney, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1025034925152 · Cited by 435
Controlled Growth Factor Delivery for Tissue Engineering
Tayalia, P., & Mooney, D. J. (2009) · Advanced Materials · doi:10.1002/adma.200900241 · Cited by 430
Wang, H., & Keiser, J. A. (1998) · Circulation Research · doi:10.1161/01.res.83.8.832 · Cited by 427
Polymeric protein delivery systems
Lee, K. Y., & Yuk, S. H. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.04.001 · Cited by 425
Angiogenesis: Where Do We Stand Now?
Simons, M. (2005) · Circulation · doi:10.1161/01.cir.0000159345.00591.8f · Cited by 411
Ylä-Herttuala, S., & Martin, J. F. (2000) · The Lancet · doi:10.1016/s0140-6736(99)04180-x · Cited by 375
Seiler, C., Pohl, T., Wustmann, K., Hutter, D., Nicolet, P.-A., Windecker, S., Eberli, F. R., & Meier, B. (2001) · Circulation · doi:10.1161/hc4201.097835 · Cited by 324
Angiogenesis in ischemic heart disease
Ware, J. A., & Simons, M. (1997) · Nature Medicine · doi:10.1038/nm0297-158 · Cited by 323
Waltenberger, J. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00228-5 · Cited by 315
The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF
Sadat, S., Gehmert, S., Song, Y.-H., Yen, Y., Bai, X., Gaiser, S., Klein, H., & Alt, E. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.058 · Cited by 300
Lung Overexpression of the Vascular Endothelial Growth Factor Gene Induces Pulmonary Edema
Kaner, R. J., Ladetto, J. V., Singh, R., Fukuda, N., Matthay, M. A., & Crystal, R. G. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.6.3779 · Cited by 277
Schwarz, E. R., Speakman, M. T., Patterson, M., Hale, S. S., Isner, J. M., Kedes, L. H., & Kloner, R. A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00522-2 · Cited by 272
Metadata
- Authors
- Lazarous, D. F., Shou, M., Scheinowitz, M., Hodge, E., Thirumurti, V., Kitsiou, A. N., Stiber, J. A., Lobo, A. D., Hunsberger, S., Guetta, E., Epstein, S. E., & Unger, E. F.
- Venue
- Circulation
- Published
- 1996-09
- Volume
- 94
- Issue
- 5
- Pages
- 1074-1082
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2082157250
- Cited by
- 386
- References
- 28
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.